A Pharmaceutical study on certain aminosalicylates /
Ibrahim Mohammed Ahmed Abdulwahid Alsharabi
A Pharmaceutical study on certain aminosalicylates / دراسة صيدلية على بعض الامينوساليسلات Ibrahim Mohammed Ahmed Abdulwahid Alsharabi ; Supervised Ahmed Abdelbary Abdelrahman , Ahmed A. Aboelwafa - Cairo : Ibrahim Mohammed Ahmed Abdulwahid Alsharabi , 2011 - 177 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Industrial Pharmacy
The recommended first - line therapy for the treatment of active symptoms induction of remission and maintenance of remission in patients with mild - to moderate ulcerative colitis (UC) is the anti inflammatory agent 5 - aminosalicylic acid (5- ASA or mesalazine ) . 5- ASA acts topically on the colonic mucosa but when orally administered it is extensively and rapidly absorbed in the small intestine
Colonic targeting Mesalazine Ulcerative colitis
A Pharmaceutical study on certain aminosalicylates / دراسة صيدلية على بعض الامينوساليسلات Ibrahim Mohammed Ahmed Abdulwahid Alsharabi ; Supervised Ahmed Abdelbary Abdelrahman , Ahmed A. Aboelwafa - Cairo : Ibrahim Mohammed Ahmed Abdulwahid Alsharabi , 2011 - 177 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Industrial Pharmacy
The recommended first - line therapy for the treatment of active symptoms induction of remission and maintenance of remission in patients with mild - to moderate ulcerative colitis (UC) is the anti inflammatory agent 5 - aminosalicylic acid (5- ASA or mesalazine ) . 5- ASA acts topically on the colonic mucosa but when orally administered it is extensively and rapidly absorbed in the small intestine
Colonic targeting Mesalazine Ulcerative colitis